Trademark: 98013119
Word
ALPHADIRECT
Status
Pending
Status Code
645
Status Date
Tuesday, April 9, 2024
Serial Number
98013119
Mark Type
4000
Filing Date
Thursday, May 25, 2023

Trademark Owner History

Classifications
5 Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy; pharmaceutical preparations for the treatment of cancer
10 Radiation therapy devices; implantable drug delivery devices, namely a radionuclide generator for targeted radiopharmaceutical therapy
42 Medical and scientific research in the areas of pharmaceutical products and radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields of immune modulation, infection, injury, inflammation, oncology/cancer, radiology, infectious, genetic, and autoimmune diseases, and radiation therapies; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy
ALPHA DIRECT

Trademark Events
Apr 9, 2024
Notification Of Final Refusal Emailed
Apr 9, 2024
Final Refusal E-Mailed
Apr 9, 2024
Final Refusal Written
Mar 21, 2024
Teas/Email Correspondence Entered
Mar 21, 2024
Correspondence Received In Law Office
Mar 21, 2024
Teas Response To Office Action Received
Feb 19, 2024
Notification Of Non-Final Action E-Mailed
Feb 19, 2024
Non-Final Action E-Mailed
Feb 19, 2024
Non-Final Action Written
Feb 19, 2024
Assigned To Examiner
Jun 26, 2023
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24